Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
50.23B
Market cap50.23B
Price-Earnings ratio
50.89
Price-Earnings ratio50.89
Dividend yield
Dividend yield
Average volume
5.70M
Average volume5.70M
High today
$87.92
High today$87.92
Low today
$85.24
Low today$85.24
Open price
$86.71
Open price$86.71
Volume
3.95M
Volume3.95M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

With a market cap of 50.23B, Edwards Lifesciences(EW) trades at $86.90. The stock has a price-to-earnings ratio of 50.89.

On 2026-08-01, Edwards Lifesciences(EW) stock traded between a low of $85.24 and a high of $87.92. Shares are currently priced at $86.90, which is +1.9% above the low and -1.2% below the high.

The Edwards Lifesciences(EW)'s current trading volume is 3.95M, compared to an average daily volume of 5.7M.

In the last year, Edwards Lifesciences(EW) shares hit a 52-week high of $96.29 and a 52-week low of $72.30.

In the last year, Edwards Lifesciences(EW) shares hit a 52-week high of $96.29 and a 52-week low of $72.30.

EW News

TipRanks 1d
Edwards Lifesciences Executive Makes Notable Move With Fresh Insider Trade

New insider activity at Edwards Lifesciences ( (EW) ) has taken place on July 30, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Pre...

Investing.com 1d
Edwards Lifesciences CVP Markowitz sells $12,587 of company stock - Investing.com

...

Edwards Lifesciences CVP Markowitz sells $12,587 of company stock - Investing.com
Simply Wall St 3d
How Stronger 2026 Sales Outlook And Q2 Results At Edwards Lifesciences Have Changed Its Investment Story

Edwards Lifesciences reported its second-quarter 2026 results in July, with sales rising to US$1,741 million from US$1,532.2 million a year earlier, while net i...

How Stronger 2026 Sales Outlook And Q2 Results At Edwards Lifesciences Have Changed Its Investment Story

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
22.6%
Sell
0%

More EW News

TipRanks 4d
Intuit downgrade, Intuitive Surgical upgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as...

TipRanks 4d
Edwards Lifesciences upgraded to Buy from Neutral at UBS

UBS upgraded Edwards Lifesciences (EW) to Buy from Neutral with a price target of $110, up from $90, after assuming coverage of the name. Edwards Lifesciences i...

Simply Wall St 6d
Edwards Lifesciences Stock Looks Rich Despite Near Fair Value

Edwards Lifesciences stock sits in an interesting spot for investors right now, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the curr...

Edwards Lifesciences Stock Looks Rich Despite Near Fair Value

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.